Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

vincristine

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Generic mfg.

Drug class:

Tubulin polymerization inhibitor

Related drugs:

No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	cisplatin + cyclophosphamide + vincristine Sensitive: A2 - Guideline cisplatin + cyclophosphamide + vincristine Sensitive : A2	cisplatin + cyclophosphamide + vincristine Sensitive: A2 - Guideline cisplatin + cyclophosphamide + vincristine Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	cisplatin + vincristine + lomustine Sensitive: A2 - Guideline cisplatin + vincristine + lomustine Sensitive : A2	cisplatin + vincristine + lomustine Sensitive: A2 - Guideline cisplatin + vincristine + lomustine Sensitive : A2
No biomarker	Acute Lymphocytic Leukemia	No biomarker	Acute Lymphocytic Leukemia	vincristine + prednisone Sensitive: A2 - Guideline vincristine + prednisone Sensitive : A2	vincristine + prednisone Sensitive: A2 - Guideline vincristine + prednisone Sensitive : A2
No biomarker	Childhood B Acute Lymphoblastic Leukemia	No biomarker	Childhood B Acute Lymphoblastic Leukemia	cytarabine + cyclophosphamide + methotrexate + vincristine + pegaspargase Sensitive: A2 - Guideline cytarabine + cyclophosphamide + methotrexate + vincristine + pegaspargase Sensitive : A2	cytarabine + cyclophosphamide + methotrexate + vincristine + pegaspargase Sensitive: A2 - Guideline cytarabine + cyclophosphamide + methotrexate + vincristine + pegaspargase Sensitive : A2
No biomarker	Childhood B Acute Lymphoblastic Leukemia	No biomarker	Childhood B Acute Lymphoblastic Leukemia	vincristine + dexamethasone + mitoxantrone + pegaspargase Sensitive: A2 - Guideline vincristine + dexamethasone + mitoxantrone + pegaspargase Sensitive : A2	vincristine + dexamethasone + mitoxantrone + pegaspargase Sensitive: A2 - Guideline vincristine + dexamethasone + mitoxantrone + pegaspargase Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	doxorubicin hydrochloride + cyclophosphamide + etoposide IV + vincristine Sensitive: A2 - Guideline doxorubicin hydrochloride + cyclophosphamide + etoposide IV + vincristine Sensitive : A2	doxorubicin hydrochloride + cyclophosphamide + etoposide IV + vincristine Sensitive: A2 - Guideline doxorubicin hydrochloride + cyclophosphamide + etoposide IV + vincristine Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	temozolomide + irinotecan + vincristine Sensitive: A2 - Guideline temozolomide + irinotecan + vincristine Sensitive : A2	temozolomide + irinotecan + vincristine Sensitive: A2 - Guideline temozolomide + irinotecan + vincristine Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	vincristine + dactinomycin Sensitive: A2 - Guideline vincristine + dactinomycin Sensitive : A2	vincristine + dactinomycin Sensitive: A2 - Guideline vincristine + dactinomycin Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	irinotecan + vincristine Sensitive: A2 - Guideline irinotecan + vincristine Sensitive : A2	irinotecan + vincristine Sensitive: A2 - Guideline irinotecan + vincristine Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	doxorubicin hydrochloride + ifosfamide + vincristine Sensitive: A2 - Guideline doxorubicin hydrochloride + ifosfamide + vincristine Sensitive : A2	doxorubicin hydrochloride + ifosfamide + vincristine Sensitive: A2 - Guideline doxorubicin hydrochloride + ifosfamide + vincristine Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	doxorubicin hydrochloride + cyclophosphamide + ifosfamide + vincristine Sensitive: A2 - Guideline doxorubicin hydrochloride + cyclophosphamide + ifosfamide + vincristine Sensitive : A2	doxorubicin hydrochloride + cyclophosphamide + ifosfamide + vincristine Sensitive: A2 - Guideline doxorubicin hydrochloride + cyclophosphamide + ifosfamide + vincristine Sensitive : A2
No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	temozolomide + irinotecan + vincristine Sensitive: A2 - Guideline temozolomide + irinotecan + vincristine Sensitive : A2	temozolomide + irinotecan + vincristine Sensitive: A2 - Guideline temozolomide + irinotecan + vincristine Sensitive : A2